~~<i id='AAA45F673D'><strike id='AAA45F673D'><tt id='AAA45F673D'><pre id='AAA45F673D'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：fashion 2025-10-01 15:17:06 Page View：352

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Court strikes down limits on filming of police in Arizona
Next article： Activists slam private health insurers over coverage restrictions

comprehensive

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

Eli Lilly’s Mounjaro succeeds in second weight

KristofferTripplaar/APThedruggiantEliLillysaidThursdaythatitsdiabetesdrugMounjarohelpedpatientswitht

In Memoriam: Notable people who died in 2023

1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

FILE-CaliforniaGov.GavinNewsomspeaksatanewsconferenceinSacramento,Calif.,onMarch16,2023.Newsomhadthr